Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1395
TNBC
Basal B
SB-3CT
MMP2/9
MMP
12084.144
uM
73.76390
626.40640
0.4245 -1.0000 0.5136 0.1446
0.7532
1.4700
HCC1395
TNBC
Basal B
Selumetinib
MEK
MAPK
12084.155
uM
inf
inf
0.8393 0.8393 0.0000 0.0192
0.4837
1.2955
HCC1395
TNBC
Basal B
Selumetinib
MEK
MAPK
12000.155
uM
80.75220
1000.00000
0.4143 -0.2078 0.1381 0.2711
0.5795
0.8592
HCC1395
TNBC
Basal B
Sigma A6730
AKT
AKT
12000.165
uM
3.01750
8.41350
-0.9985 -1.0000 1.0714 0.3839
0.9739
0.6978
HCC1395
TNBC
Basal B
Sigma A6730
AKT
AKT
12084.158
uM
9.55270
16.05570
-0.9851 -1.0000 2.1158 0.2902
0.9749
1.2976
HCC1395
TNBC
Basal B
Sirolimus
MTOR
MTOR
7815.068
uM
0.33863
17.8570
-0.6440 -1.0000 0.2771 0.5446
0.7812
0.3490
HCC1395
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7435.084
uM
inf
inf
0.8055 0.8055 0.0000 0.0826
0.0062
0.8646
HCC1395
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7436.085
uM
50.84190
63.00890
-0.9613 -0.9617 5.0000 0.2367
0.9976
1.2621
HCC1395
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7435.067
uM
inf
inf
-0.9999 -0.9999 0.0000 0.3882
0.4920
0.7691
HCC1395
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7436.067
uM
6.28170
9.30690
-0.9870 -0.9914 2.7800 0.4448
0.9986
1.2834
HCC1395
TNBC
Basal B
TAPI-0
TACE/Collagenase
7436.096
uM
inf
1.39810
0.7383 0.7555 5.0000 0.0724
0.8656
1.3979
HCC1395
TNBC
Basal B
Taxol
TUBB
TUBB
7813.002
uM
0.01747
0.02423
-0.4841 -0.4403 1.9311 0.8608
0.9310
0.8463
HCC1395
TNBC
Basal B
Taxol
TUBB
TUBB
9254.002
uM
0.02485
0.02967
-0.9237 -0.7129 5.0000 0.9198
0.9866
0.3983
HCC1395
TNBC
Basal B
Taxol
TUBB
TUBB
9258.002
uM
0.00994
0.01669
-0.7912 -0.7141 1.7129 1.0122
0.9961
0.7065
HCC1395
TNBC
Basal B
TCS 2312
CHK1
CHK
12000.159
uM
0.07351
0.25344
-0.9026 -0.8763 0.8181 0.7327
0.9820
0.9695
HCC1395
TNBC
Basal B
TCS 2312
CHK1
CHK
12084.159
uM
0.12645
0.46266
-0.9712 -1.0000 0.8469 0.6667
0.9938
1.2294
HCC1395
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
12084.135
uM
inf
inf
0.7668 0.7668 0.0000 0.1076
0.3172
1.4162
HCC1395
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
12000.135
uM
64.49110
29.37550
0.4905 0.4902 4.9993 0.0955
0.7497
0.6914
HCC1395
TNBC
Basal B
Temsirolimus
MTOR
MTOR
12000.168
uM
4.0130
18.40320
-0.9948 -1.0000 0.7214 0.4420
0.8575
0.7873
HCC1395
TNBC
Basal B
Temsirolimus
MTOR
MTOR
12084.144
uM
24.82360
38.21160
-0.9756 -1.0000 2.5470 0.3146
0.9202
1.4700
HCC1395
TNBC
Basal B
Topotecan
TOP1
TOP
9258.121
uM
0.00349
0.01125
-0.9927 -0.9212 0.8921 1.3529
0.9299
0.4800
HCC1395
TNBC
Basal B
Topotecan
TOP1
TOP
7813.007
uM
0.01486
0.14163
-0.8539 -0.9671 0.4774 1.0047
0.9544
0.8361
HCC1395
TNBC
Basal B
Topotecan
TOP1
TOP
7816.007
uM
0.00871
0.04726
-0.6908 -0.6747 0.5051 0.9894
0.9549
1.1536
HCC1395
TNBC
Basal B
Topotecan
TOP1
TOP
9254.121
uM
0.01853
0.07031
-0.6563 -0.6590 0.6304 0.9209
0.9597
1.2352
HCC1395
TNBC
Basal B
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12000.169
uM
2.54270
8.67140
-0.9866 -1.0000 0.8955 0.4942
0.9205
0.8565